Heron Therapeutics to report Q2 2026 financial results on August 10, 2026

Heron Therapeutics, a commercial-stage biotech company, announced it will release its second quarter 2026 financial results on August 10, 2026. The company will hold a conference call and webcast at 8:30 a.m. ET to discuss the results and recent business updates. Investors can access the call via phone or webcast through Heron's website, with an archive available for 60 days. This report will provide insights into Heron's financial performance and ongoing developments in its therapeutic product portfolio.